Security key
929033207
Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR)
CUSIP: 929033207
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 51,352,293
- Total 13F shares
- 40,448,699
- Share change
- +14,037,614
- Total reported value
- $716,851,001
- Price per share
- $17.84
- Number of holders
- 80
- Value change
- +$247,955,353
- Number of buys
- 57
- Number of sells
- 18
Report period
Q1 2026
Institutions
80
Top holders
10
VOR full security history
Previous quarter: Q4 2025
Vor Biopharma Inc. SEC filings
Vor Biopharma Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 929033207
Recent filing periods:
Top shareholders of VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC |
13D/G
3/4/5
|
10%+ Owner |
18%
|
1,204,442
|
$48,045,191 | $0 | 15 Oct 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
|
Company |
14%
from 13D/G
|
5,404,998
|
$70,697,374 | — | 31 Dec 2025 | |
| TCG Crossover GP II, LLC |
3/4/5
13D/G
|
10%+ Owner · Chen Yu |
10%
from 13D/G
|
2,836,539
|
$37,101,930 | — | 30 Mar 2026 | |
| ForGrowth III PA B.V. |
13D/G
|
— |
10%
|
10,237,714
|
$81,492,203 | +$25,772,203 | 18 Dec 2025 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
9.9%
|
5,083,877
|
$91,763,980 | +$51,763,826 | 31 Mar 2026 | |
| Verve Capital Ltd |
13D/G
|
Verve Capital Limited |
9.3%
|
4,999,272
|
$90,236,860 | +$12,667,634 | 31 Mar 2026 | |
| Frazier Life Sciences Public Fund, L.P. |
13D/G
|
— |
5.8%
|
2,258,001
|
$17,973,688 | $0 | 18 Dec 2025 | |
| Paradigm Biocapital Advisors LP |
13D/G
13F
|
Company |
4.5%
|
1,750,000
|
$23,730,000 | $0 | 31 Dec 2025 | |
| 5AM Ventures VI, L.P. |
13D/G
3/4/5
|
Andrew J. Schwab · 10%+ Owner |
3.5%
|
4,422,863
|
$4,422,863 | $0 | 08 Jul 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
13F
|
Company |
3.3%
|
1,370,107
|
$18,578,651 | +$1,839,021 | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
3.2%
from 13D/G
|
2,526,170
|
$33,042,304 | — | 31 Dec 2025 | |
| Qiming Venture Partners VIII-HC, L.P. |
13D/G
|
— |
2%
|
1,089,767
|
$19,670,294 | $0 | 31 Mar 2026 | |
| TCG Crossover Fund II, L.P. |
3/4/5
|
10%+ Owner |
5.5%
|
2,836,539
|
$37,101,930 | — | 30 Mar 2026 | |
| TCG Crossover Fund III, L.P. |
3/4/5
|
10%+ Owner |
5.5%
|
2,836,539
|
$37,101,930 | — | 30 Mar 2026 | |
| TCG Crossover GP III, LLC |
3/4/5
|
10%+ Owner |
5.5%
|
2,836,539
|
$37,101,930 | — | 30 Mar 2026 | |
| FCPM III SERVICES B.V. |
13F
|
Company |
7%
|
3,617,354
|
$47,314,990 | — | 31 Dec 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5%
|
2,543,939
|
$33,274,722 | — | 31 Dec 2025 | |
| Venrock Adviser, LLC |
13F
|
Company |
3.8%
|
1,943,766
|
$25,424,459 | — | 31 Dec 2025 | |
| NEXTBio Capital Management LP |
13F
|
Company |
1.9%
|
999,967
|
$13,079,568 | — | 31 Dec 2025 | |
| Caligan Partners LP |
13F
|
Company |
1.8%
|
925,067
|
$9,962,972 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
770,250
|
$10,074,870 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.91%
|
465,636
|
$6,090,520 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.84%
|
433,894
|
$5,675,334 | — | 31 Dec 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.8%
|
410,417
|
$5,368,254 | — | 31 Dec 2025 | |
| Laurion Capital Management LP |
13F
|
Company |
0.62%
|
317,243
|
$4,149,538 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.57%
|
292,118
|
$3,820,904 | — | 31 Dec 2025 | |
| FINDELL CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.45%
|
231,000
|
$3,021,480 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.44%
|
224,534
|
$2,936,905 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
185,808
|
$2,431,650 | — | 31 Dec 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.33%
|
167,673
|
$2,193,163 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.32%
|
163,061
|
$2,132,838 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.28%
|
145,640
|
$1,904,971 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.19%
|
100,000
|
$1,308,000 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
91,810
|
$1,200,875 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
91,053
|
$1,190,973 | — | 31 Dec 2025 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.1%
|
53,732
|
$702,815 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
38,946
|
$509,414 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
28,463
|
$372,296 | — | 31 Dec 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.05%
|
28,204
|
$368,908 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.05%
|
26,791
|
$350,426 | — | 31 Dec 2025 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.05%
|
25,399
|
$332,219 | — | 31 Dec 2025 | |
| Bollard Group LLC |
13F
|
Company |
0.05%
|
23,987
|
$314,000 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.04%
|
20,700
|
$270,756 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
18,459
|
$241,444 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
17,542
|
$229,449 | — | 31 Dec 2025 | |
| INDEPENDENT FINANCIAL GROUP, LLC |
13F
|
Company |
0.03%
|
17,000
|
$222,360 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
14,819
|
$193,833 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.02%
|
10,798
|
$141,238 | — | 31 Dec 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.02%
|
10,745
|
$140,545 | — | 31 Dec 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.02%
|
10,207
|
$133,508 | — | 31 Dec 2025 |
Institutional Holders of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) as of Q1 2026
As of 31 Mar 2026,
Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,448,699 shares.
The largest 10 holders included
TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., Venrock Adviser, LLC, Frazier Life Sciences Management, L.P., Caligan Partners LP, GREAT POINT PARTNERS LLC, Paradigm Biocapital Advisors LP, FMR LLC, and VANGUARD CAPITAL MANAGEMENT LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
54
Q1 2026 holders
80
Holder diff
26
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.